Literature DB >> 31797579

Analysis of Protein-Protein Interactions by Split Luciferase Complementation Assay.

Yuekun Lang1, Zhong Li1, Hongmin Li1,2.   

Abstract

Protein-protein interactions are important in human disease. Developing and refining tools to understand physical contacts between signaling proteins is crucial. This article describes a split luciferase complementation (SLC) method designed to discover inhibitors of protein-protein interaction. Different fusion proteins with split luciferase are constructed, expressed, and purified, and then assessed to determine the best pair that generates the strongest luminescence. SLC specificity and affinity are further confirmed. Step-by-step instructions are provided for performing these assays using the NS2B-NS3 interaction as an example. NS2B is an essential cofactor for flaviviral NS3 protease function. Advantages and disadvantages of these assays are further discussed.
© 2019 by John Wiley & Sons, Inc. Basic Protocol 1: Expression and purification of fusion proteins Basic Protocol 2: Analysis of prey/bait pairs by SLC-based NS2B-NS3 interaction assay Support Protocol 1: Interaction specificity assay Support Protocol 2: Competition binding assay: Dose-response inhibition using cold prey or bait Support Protocol 3: Competition binding assay: Inhibition by MBP-NS3 versus irrelevant MBP tag Support Protocol 4: SLC-based NS2B-NS3 interaction assay using NS2B mutations known to disrupt NS2B-NS3 interactions. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  NS2B-NS3; flaviviral protease; protein-protein interaction; split luciferase complementation

Year:  2019        PMID: 31797579      PMCID: PMC7269092          DOI: 10.1002/cptx.90

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  18 in total

1.  Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies.

Authors:  R Paulmurugan; Y Umezawa; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

Review 2.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

3.  A general and rapid cell-free approach for the interrogation of protein-protein, protein-DNA, and protein-RNA interactions and their antagonists utilizing split-protein reporters.

Authors:  Jason R Porter; Cliff I Stains; Benjamin W Jester; Indraneel Ghosh
Journal:  J Am Chem Soc       Date:  2008-04-29       Impact factor: 15.419

4.  Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assay.

Authors:  Tadafumi Hashimoto; Kenneth W Adams; Zhanyun Fan; Pamela J McLean; Bradley T Hyman
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 5.  Firefly luciferase inhibition.

Authors:  João M M Leitão; Joaquim C G Esteves da Silva
Journal:  J Photochem Photobiol B       Date:  2010-07-03       Impact factor: 6.252

6.  Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.

Authors:  Zhong Li; Matthew Brecher; Yong-Qiang Deng; Jing Zhang; Srilatha Sakamuru; Binbin Liu; Ruili Huang; Cheri A Koetzner; Christina A Allen; Susan A Jones; Haiying Chen; Na-Na Zhang; Min Tian; Fengshan Gao; Qishan Lin; Nilesh Banavali; Jia Zhou; Nathan Boles; Menghang Xia; Laura D Kramer; Cheng-Feng Qin; Hongmin Li
Journal:  Cell Res       Date:  2017-07-07       Impact factor: 25.617

7.  A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5.

Authors:  M Farzan; H Choe; L Vaca; K Martin; Y Sun; E Desjardins; N Ruffing; L Wu; R Wyatt; N Gerard; C Gerard; J Sodroski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals.

Authors:  Kathryn E Luker; Matthew C P Smith; Gary D Luker; Seth T Gammon; Helen Piwnica-Worms; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-29       Impact factor: 11.205

9.  A novel luminescent biosensor for rapid monitoring of IP3 by split-luciferase complementary assay.

Authors:  Farangis Ataei; Masoud Torkzadeh-Mahani; Saman Hosseinkhani
Journal:  Biosens Bioelectron       Date:  2012-10-11       Impact factor: 10.618

10.  A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis.

Authors:  Venugopal Panga; Srivatsan Raghunathan
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

View more
  4 in total

1.  Development and characterization of an inducible assay system to measure Zika virus capsid interactions.

Authors:  Jieshi Yu; Chen Huang; Zhao Wang; Radhey S Kaushik; Zizhang Sheng; Feng Li; Dan Wang
Journal:  J Med Virol       Date:  2022-07-23       Impact factor: 20.693

2.  In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiangmeng Wu; Saiyang Hu; Subodh Kumar Samrat; Anil M Tharappel; Lili Kuo; David Butler; Yongcheng Song; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

3.  JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiaoyu Fan; Lili Kuo; Lianna D'Brant; Saiyang Hu; Subodh Kumar Samrat; Nicole Trudeau; Anil M Tharappel; Natasha Rugenstein; Cheri A Koetzner; Jing Zhang; Haiying Chen; Laura D Kramer; David Butler; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  ACS Infect Dis       Date:  2020-09-21       Impact factor: 5.084

4.  Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo.

Authors:  Zhong Li; Yuekun Lang; Srilatha Sakamuru; Subodh Samrat; Nicole Trudeau; Lili Kuo; Natasha Rugenstein; Anil Tharappel; Lianna D'Brant; Cheri A Koetzner; Saiyang Hu; Jing Zhang; Ruili Huang; Laura D Kramer; David Butler; Menghang Xia; Hongmin Li
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.